139 related articles for article (PubMed ID: 8938517)
41. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
Piacibello W; Garetto L; Sanavio F; Severino A; Fubini L; Stacchini A; Dragonetti G; Aglietta M
Exp Hematol; 1996 Feb; 24(2):340-6. PubMed ID: 8641363
[TBL] [Abstract][Full Text] [Related]
42. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells.
Brandt JE; Bhalla K; Hoffman R
Blood; 1994 Mar; 83(6):1507-14. PubMed ID: 7510143
[TBL] [Abstract][Full Text] [Related]
43. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro.
Namikawa R; Muench MO; de Vries JE; Roncarolo MG
Blood; 1996 Mar; 87(5):1881-90. PubMed ID: 8634436
[TBL] [Abstract][Full Text] [Related]
44. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
Muench MO; Schneider JG; Moore MA
Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
[TBL] [Abstract][Full Text] [Related]
45. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells.
Bárcena A; Muench MO; Song KS; Ohkubo T; Harrison MR
Exp Hematol; 1999 Sep; 27(9):1428-39. PubMed ID: 10480434
[TBL] [Abstract][Full Text] [Related]
46. Proliferation of human progenitor cells in a long-term culture system is more efficiently sustained by the addition of Flt-3 ligand or megakaryocyte growth and development factor than by Kit ligand.
Cartron G; Binet C; Hérault O; Cailliot C; Bernard MC; Estienne MH; Clément N; Colombat P; Domenech J
Int J Hematol; 2003 Feb; 77(2):133-41. PubMed ID: 12627848
[TBL] [Abstract][Full Text] [Related]
47. Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells.
Sasnoor LM; Kale VP; Limaye LS
J Hematother Stem Cell Res; 2003 Oct; 12(5):553-64. PubMed ID: 14594512
[TBL] [Abstract][Full Text] [Related]
48. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
[TBL] [Abstract][Full Text] [Related]
49. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
50. Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media.
Koller MR; Maher RJ; Manchel I; Oxender M; Smith AK
J Hematother; 1998 Oct; 7(5):413-23. PubMed ID: 9829315
[TBL] [Abstract][Full Text] [Related]
51. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division.
Murray LJ; Young JC; Osborne LJ; Luens KM; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):1019-28. PubMed ID: 10378891
[TBL] [Abstract][Full Text] [Related]
52. Effects of CD34+ cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells.
Sandstrom CE; Bender JG; Papoutsakis ET; Miller WM
Blood; 1995 Aug; 86(3):958-70. PubMed ID: 7542506
[TBL] [Abstract][Full Text] [Related]
53. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver.
Bárcena A; Park SW; Banapour B; Muench MO; Mechetner E
Blood; 1996 Sep; 88(6):2013-25. PubMed ID: 8822920
[TBL] [Abstract][Full Text] [Related]
54. Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors.
Piacibello W; Fubini L; Sanavio F; Brizzi MF; Severino A; Garetto L; Stacchini A; Pegoraro L; Aglietta M
Blood; 1995 Dec; 86(11):4105-14. PubMed ID: 7492767
[TBL] [Abstract][Full Text] [Related]
55. Enhanced effect of vascular endothelial growth factor, thrombopoietin peptide agonist, SCF, and Flt3-L on LTC-IC and reporter gene transduction from umbilical cord blood CD34+ cells.
Smith SL; Kiss J; Siatskas C; Medin JA; Moldwin RL
Transfusion; 2004 Mar; 44(3):438-49. PubMed ID: 14996204
[TBL] [Abstract][Full Text] [Related]
56. Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.
Ratajczak MZ; Kuczynski WI; Sokol DL; Moore JS; Pletcher CH; Gewirtz AM
Blood; 1995 Sep; 86(6):2161-7. PubMed ID: 7545021
[TBL] [Abstract][Full Text] [Related]
57. Synergy of growth factors during mobilization of peripheral blood precursor cells with recombinant human Flt3-ligand and granulocyte colony-stimulating factor in rabbits.
Pless M; Wodnar-Filipowicz A; John L; Baldomero H; Lyman SD; Nissen C; Gratwohl A
Exp Hematol; 1999 Jan; 27(1):155-61. PubMed ID: 9923454
[TBL] [Abstract][Full Text] [Related]
58. Colony-forming cells expressing high levels of CD34 are the main targets for granulocyte colony-stimulating factor and macrophage colony-stimulating factor in the human fetal liver.
Muench MO; Roncarolo MG; Rosnet O; Birnbaum D; Namikawa R
Exp Hematol; 1997 Apr; 25(4):277-87. PubMed ID: 9131001
[TBL] [Abstract][Full Text] [Related]
59. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
Miller JS; McCullar V; Verfaillie CM
Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147
[TBL] [Abstract][Full Text] [Related]
60. Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors.
List AF; Heaton R; Glinsmann-Gibson B; Capizzi RL
Leukemia; 1998 Oct; 12(10):1596-602. PubMed ID: 9766505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
